The Vascular Access Devices market size is expected to increase due to the factors such as the growing prevalence of chronic diseases like cancer, kidney failure, and heart diseases that require the use of these devices. Some other factors like the rise in the number of chemotherapies, lifestyle diseases, and their rising occurrence in pediatric patients will also drive the Vascular Access Devices market growth.
DelveInsight’s Vascular Access Devices Market Insights report provides the current and forecast market, upcoming device innovation, individual leading companies market shares, challenges, market drivers, barriers, and trends, and key Vascular Access Devices companies in the market.
Interested in knowing how the Vascular Access Devices market size will be growing by 2026? Click to get a snapshot of Vascular Access Devices Market Growth Analysis
Vascular Access Devices
Vascular Access Devices are types of equipment that are put into the body through a vein to allow fluids, blood products, medicine, and other therapies to be administered to the bloodstream. Vascular Access devices provide recurrent and long-term access to the bloodstream for the delivery of medications such as intravenous (IV) antibiotics. Silicone, latex, and other materials are used to make the vascular access tubes.
Vascular Access Devices can be inserted through a variety of veins, including the internal jugular, subclavian, external jugular, and femoral veins. Totally implantable vascular access device (TIVAD), also known as vascular access ports, are made up of a well with a self-sealing septum, which is normally placed within a titanium cover and connected to a silicone catheter. The other implanted vascular access device such as Dual septum/lumen ports are also available, however, they are somewhat big.
Vascular Access Devices Market Insights
North America is likely to lead the global Vascular Access Devices market during the forecasted period. This dominance is due to the increased need for innovative technology in vascular access devices, as well as the region’s increasing need to treat chronic renal disease, which is driving regional Vascular Access Devices market growth.
Furthermore, due to the growing geriatric population in the United States, the chance of contracting a chronic disease is rising rapidly. This circumstance has created an urgent demand for vascular access devices for chronic diseases detection, prevention, and treatment. Thus, thereby boosting the Vascular Access Devices market size.
Moreover, Europe and the Asia-Pacific region have the most potential for growth in the Global Vascular Access Devices market. This is related to the increasing burden of chronic diseases in European and Asian nations.
To know more why North America is leading the market growth in the Vascular Access Devices market, get a snapshot of the report Global Vascular Access Devices Market Outlook
Recent Developments in the Vascular Access Devices Market Report
- In August 2021, PuraCath Medical™, a venture-backed startup company focusing on the development of technologies to reduce infections in patients with intravascular catheters, announced that it has received 510(k) clearance for its FireFly™ Needleless Connector from the FDA. The Firefly™ Needleless Connector is a sterile single patient use connector for needleless access to the IV line and IV catheter during IV therapy and can be used for direct injection, intermittent infusion, continuous infusion, or aspiration. This regulatory determination by the FDA gives PuraCath clearance to market the FireFly™ needleless connector in the US.
- In July 2021, Artio Medical, Inc., a medical device company developing peripheral vascular access device along with innovative vascular access products for neurovascular, and structural heart markets, announced it has completed enrolment in its first-in-human study evaluating the company’s Amplifi™ Vein Dilation System. The Amplifi System is designed to stimulate arm vein enlargement in hemodialysis patients using rapid, non-pulsatile venous blood flow. Novel vein dilation system aims to improve vascular access device for hemodialysis patients.
Interested in knowing about the advancements in Vascular Access Devices? Click to get a snapshot of Vascular Access Closure Devices
Key Players in the Vascular Access Devices Market
The leading Vascular Access Devices companies with various types of Vascular Access Devices in various stages of development such as Cook Medical Inc., Becton, Dickinson, and Company, Teleflex Incorporated, Medtronic PLC, Zoll Medical Corporation, B Braun Melsungen AG, Prodimed, Amecath Medical Technologies, Terumo Medical Corporation, AngioDynamics, Edwards Lifesciences Corporation, C. R. Bard, Inc., Smiths Group PLC, Nipro Medical Corporation, and others are currently working in the Vascular Access Devices market.
Vascular Access Devices Market Dynamics
The demand for Vascular Access Devices is primarily motivated by the growing prevalence of chronic diseases like cancer, kidney failure, and heart diseases that require the use of these devices. Some other factors like the rise in the number of chemotherapies, lifestyle diseases, and their rising occurrence in pediatric patients may also drive the Vascular Access Devices market growth.
Moreover, vascular access catheter devices are also widely utilized in chemotherapy operations. Vascular access techniques are increasingly being employed for intravenous therapy, intravenous nutritional support, and diagnostic reasons, due to lower-cost catheter devices with decreased failure rates. As a result, various medical device companies will be enticed to invest in and introduce new Vascular Access products, functioning as one of the primary drivers for this industry. As a result, all of these factors are expected to propel the Global Vascular Access Devices market forward.
Get a sneak peek at the Vascular Access Devices market dynamics @ Vascular Access Devices Market Dynamics Analysis
Scope of the Vascular Access Devices Market Report
- Coverage: Global
- Study Period: 2018-2026
- Market Segmentation By Vascular Access Device Types – Central Vascular Access Devices-Peripherally Inserted Central Catheters, Non-Tunneled Catheters, Others, and Peripheral Vascular Access Device- Peripheral Catheter, Midline Catheter (Short) Devices, and Others
- Market Segmentation By Route of Insertion – Intravenous, Subcutaneous
- Market Segmentation By End-User – Hospitals, Ambulatory Surgical Centers, and Others
- Market Segmentation By Geography – North America, Europe, Asia-Pacific, and Rest of World
- Key Vascular Access Devices Companies – Cook Medical Inc. (NYSE: COOK), Becton, Dickinson, and Company (NYSE: BDX), Teleflex Incorporated (NYSE: TFX), Medtronic PLC (NYSE: MDT), Zoll Medical Corporation, B Braun Melsungen AG, Prodimed, Amecath Medical Technologies, Terumo Medical Corporation, AngioDynamics (NASDAQ: ANGO), Edwards Lifesciences Corporation (NYSE: EW), C. R. Bard, Inc., Smiths Group PLC (LON: SMIN), Nipro Medical Corporation among others
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL’s Views, Analyst’s View
DelveInsight Analysis: The Vascular Access Devices market size is expected to grow at a CAGR of 6.64% during the forecast period from 2021 to 2026 to reach USD 6.13 billion by 2026.
Which MedTech key players in the Vascular Access Devices market are set to emerge as the trendsetter explore @ Vascular Access Devices Companies
Table of Contents
| 1 | Vascular Access Devices Market Report Introduction |
| 2 | Vascular Access Devices Market Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Vascular Access Devices Market Key Factors Analysis |
| 5 | Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Vascular Access Devices Market |
| 7 | Vascular Access Devices Market Layout |
| 8 | Vascular Access Devices Global Company Share Analysis – Key 3-5 Companies |
| 9 | Vascular Access Devices Market Company and Product Profiles |
| 10 | Project Approach |
Learn more about the vascular access closure devices @ Vascular Access Device Management
Related Reports
Peripheral Vascular Devices Market
Peripheral Vascular Devices Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Peripheral Vascular Devices companies such as Medtronic, Boston Scientific Corporation, B. Braun Melsungen AG, Braile Biomedica, JOTEC GmbH, Edwards LifeSciences Corporation, among others.
Peripherally Inserted Central Catheters (PICC) Market
Peripherally Inserted Central Catheters Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Peripherally Inserted Central Catheters companies such as AngioDynamics Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Teleflex Incorporated, among others.
Vascular Closure Devices Market
Vascular Closure Devices Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Vascular Closure Devices companies such as Abbott, Teleflex Incorporated, Terumo Medical Corporation, Cardinal Health, among others.
Vascular Graft Devices Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Vascular Graft Devices companies such as BD, Getinge AB, Medtronic, B. Braun Melsungen AG, Cardinal Health, Terumo Corporation, among others.
Peripheral Vascular Clot Management Interventions Market
Peripheral Vascular Clot Management Interventions Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Peripheral Vascular Clot Management Interventions companies such as Boston Scientific Corporation, Penumbra Inc, Medtronic, Koninklijke Philips N.V., Edward LifeSciences Corporation, Cardinal Health, among others.
Vascular Stents Market Insight, Competitive Landscape, and Market Forecast, 2026 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Vascular Stents companies such as Medtronic, Abbott, Boston Scientific Corporation, BIOTRONIK SE & Co. KG, B. Braun Melsungen AG, among others.
Other Trending Reports
Follicular Lymphoma Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, along with emerging drugs and key Follicular Lymphoma companies such as Merck & Co, Genentech, Incyte Corporation, Syndax Pharmaceuticals, among others.
Renal Vasculitis Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, along with emerging drugs and key Renal Vasculitis companies operating in the domain.
Cancer Pain Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Cancer Pain companies such as vTv Therapeutics, AstraZeneca, Janssen, among others.
Chronic Phase Chronic Myeloid Leukemia Market
Chronic Phase Chronic Myeloid Leukemia Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Chronic Phase Chronic Myeloid Leukemia companies such as Bristol-Myers Squibb, AOP Orphan Pharmaceuticals, Medical College of Wisconsin, Chia Tai Tianqing Pharmaceutical, among others.
Hormone Sensitive Advanced Prostate Cancer Market
Hormone Sensitive Advanced Prostate Cancer Market Insight, Epidemiology, and Market Forecast, 2032 report delivers an in-depth understanding of market trends, market drivers, market barriers, and key Hormone Sensitive Advanced Prostate Cancer companies such as Ferring Pharmaceuticals, among others.
Related Healthcare Blogs
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
Contact Us
Shruti Thakur
info@delveinsight.com
+1(919)321-6187